I am a cat owner, and like many others, my life has been touched by the devastating impact of Feline Infectious Peritonitis (FIP). This viral disease is caused by a mutation of the common feline coronavirus. Without treatment, it's incurable and 100% fatal.

Gilead Sciences, Inc., a pharmaceutical company, invented and patented GS-441524 - a drug that could potentially save thousands - if not millions - of cats' lives every day. However, they have refused to license this drug for animal use due to fears that its similarity to Remdesivir could interfere with the human drug's FDA-approval process - originally intended for Ebola.

This decision leaves countless cats at risk of losing their lives to an otherwise treatable disease. It is heartbreaking for cat owners like myself who are left feeling helpless as we watch our beloved pets suffer.

We understand the importance of human healthcare but believe that animal health should not be compromised in this process. We urge Gilead Sciences Inc., to reconsider their stance on GS-441524.

By approving this drug for veterinary use, we can give hope to hundreds of thousands of pet owners worldwide and save countless feline lives from FIP.

Please sign this petition urging Gilead Sciences Inc., and the FDA to approve GS-441524 for animal use.